ImpeDx Diagnostics

About:

ImpeDx Diagnostics, a start-up medical device company.

Website: http://impedx.com/

Top Investors: National Science Foundation

Description:

ImpeDx Diagnostics is a start-up medical device company founded in 2013, that has secured exclusive rights to develop and market a novel system for rapid detecting bacteria in blood culture specimens for use in clinical laboratories. Their mission is to reduce the mortality rate of septic patients by providing rapid diagnostic products, which will allow clinicians to administer target therapeutic treatments sooner. Their technology compresses blood culture results from days to hours. Not only will rapid identification improve the mortality rate, but it will also have a major impact on healthcare savings.

Total Funding Amount:

$1.29M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Leawood, Kansas, United States

Founded Date:

2013-01-01

Contact Email:

steve.oconnor(AT)impedx.com

Founders:

Kim Mislick, Shramik Sengupta, Stephen O’Connor

Number of Employees:

1-10

Last Funding Date:

2018-09-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai